Unique ID issued by UMIN | UMIN000003565 |
---|---|
Receipt number | R000004325 |
Scientific Title | Randomized controlled trial of percutaneous transesophageal gastric tubing (PTEG) in patients with gastrointestinal obstruction from cancer (JIVROSG-0805) |
Date of disclosure of the study information | 2010/05/05 |
Last modified on | 2019/05/19 15:56:24 |
Randomized controlled trial of percutaneous transesophageal gastric tubing (PTEG) in patients with gastrointestinal obstruction from cancer (JIVROSG-0805)
Randomized controlled trial of percutaneous transesophageal gastric tubing (PTEG) in patients with gastrointestinal obstruction
Randomized controlled trial of percutaneous transesophageal gastric tubing (PTEG) in patients with gastrointestinal obstruction from cancer (JIVROSG-0805)
Randomized controlled trial of percutaneous transesophageal gastric tubing (PTEG) in patients with gastrointestinal obstruction
Japan |
Gastrointestinal obstruction from cancer
Radiology |
Malignancy
NO
To evaluate the clinical efficacy of percutaneous transesophageal gastric tubing (PTEG) in patients with gastrointestinal obstruction from cancer comparing with conventional nasal gastric tubing.
Efficacy
Confirmatory
Pragmatic
Phase III
Improvement of the symptoms from nasal gastric tubing.
Improvement of health-related QOL and toxicity profile.
Interventional
Parallel
Randomized
Individual
Open -but assessor(s) are blinded
Active
YES
YES
Institution is considered as adjustment factor in dynamic allocation.
NO
Central registration
2
Treatment
Device,equipment | Maneuver |
Percutaneous transesophageal gastric tubing (PTEG)
Nasal gastric tubing
Not applicable |
Not applicable |
Male and Female
1. Gastrointestinal obstruction from cancer, such as upper GI obstruction from tumor or peritonitis, without possibility of symptom improvement by conventional treatments.
2. Contraindication to surgical treatments for gastrointestinal obstruction.
3. No disorder in the region of cervical esophagus.
4. Palliative prognosis index less than 6.
5. Twice measurement of symptom score and health-related quality-of-life.
6. Written informed consent from the patients.
1. Tracheal stoma by tracheostomy.
2. GI obstruction resulting from the lesion distal (annal side) to transverse colon.
3. Platelet count <50,000/mm3.
4. Locoregional treatment in the neck or planned locoregional treatment in the neck.
5. Pregnancy.
6. Contraindication decided by participating physician.
40
1st name | Takeshi |
Middle name | |
Last name | Aramaki |
Shizuoka Cancer Center
Department of Imaging Diagnosis
411-8777
Shunto-gun, Shizuoka, Japan
03-3542-2511
msone@athena.ocn.ne.jp
1st name | Yasuaki |
Middle name | |
Last name | Arai |
National Cancer Center Hospital
Department of Diagnostic Radiology
1040045
5-1-1,Tsukiji,Chuo-ku,Tokyo,104-0045,Japan
03-3542-2511
http://jivrosg.umin.jp/
arai-y3111@mvh.biglobe.ne.jp
Japan Interventional Radiology in Oncology Study Group (JIVROSG)
Ministry of Health, Labour and Welfare
Japanese Governmental office
Japan
National Cancer Center Hospital
5-1-1,Tsukiji,Chuo-ku,Tokyo,104-0045,Japan
03-3542-2511
msone@me.com
NO
愛知県がんセンター中央病院(愛知県)、旭川厚生病院(北海道)、岩手医科大学(岩手県)、群馬大学医学部附属病院(群馬県)、国立がんセンター中央病院(東京都)、静岡県立静岡がんセンター(静岡県)、手稲渓仁会病院(北海道)、栃木県立がんセンター(栃木県)
2010 | Year | 05 | Month | 05 | Day |
Unpublished
Enrolling by invitation
2008 | Year | 08 | Month | 06 | Day |
2009 | Year | 09 | Month | 24 | Day |
2009 | Year | 11 | Month | 01 | Day |
2015 | Year | 02 | Month | 28 | Day |
2010 | Year | 05 | Month | 05 | Day |
2019 | Year | 05 | Month | 19 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004325